Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Sundry Debtors

    Back to Balance Sheet
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Sundry Debtors History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Sundry Debtors ₹1,858 Cr₹3,665 Cr₹3,101 Cr₹2,572 Cr₹2,409 Cr

What is the latest Sundry Debtors ratio of GLENMARK PHARMACEUTICALS ?

The latest Sundry Debtors ratio of GLENMARK PHARMACEUTICALS is ₹1,858 Cr based on Mar2024 Consolidated results.
Year Sundry Debtors
Mar2024₹1,858 Cr
Mar2023₹3,665 Cr
Mar2022₹3,101 Cr
Mar2021₹2,572 Cr
Mar2020₹2,409 Cr

How is Sundry Debtors of GLENMARK PHARMACEUTICALS Trending?

Years Sundry Debtors % Change
Mar2024 ₹1,858 Cr
-49.30
Mar2023 ₹3,665 Cr
18.19
Mar2022 ₹3,101 Cr
20.57
Mar2021 ₹2,572 Cr
6.77
Mar2020 ₹2,409 Cr -

Compare Sundry Debtors of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹40,842.8 Cr 4.8% 5.2% 40% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹416,273.0 Cr 2.9% 1.8% 14% Stock Analytics
DIVIS LABORATORIES ₹166,750.0 Cr 5.7% 9.6% 58.6% Stock Analytics
CIPLA ₹121,122.0 Cr -0.8% 1.2% 6.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,487.0 Cr 0.8% 1.2% 25.4% Stock Analytics
DR REDDYS LABORATORIES ₹102,680.0 Cr 2.9% 6.5% 4.3% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

4.8%

5.2%

40%

SENSEX

3.6%

9.5%

13.3%


You may also like the below Video Courses